Vascular Graft Solutions

Vascular Graft Solutions (VGS) is a medical technology company based in Tel Aviv, Israel, founded in 2009 by Dr. Eyal Orion. The company specializes in developing technologies aimed at improving cardiovascular surgery, particularly coronary artery bypass grafting (CABG), which is the most common cardiac surgery globally. VGS addresses key challenges in CABG, such as the durability of vein grafts and complications related to the procedure. The company has developed four products, including its flagship device, VIOLA™, which facilitates clampless proximal anastomosis during CABG. This innovative design allows for multiple aortic anastomoses with optimal hemostasis, reducing the risk of stroke and other complications. VGS focuses on enhancing patient outcomes and quality of life while also aiming to lower healthcare costs through advancements in surgical revascularization and vascular reconstruction. With a commitment to evidence-based solutions, VGS is dedicated to improving both short- and long-term outcomes in coronary bypass surgery, serving cardiac surgeons and healthcare systems worldwide.

• Employees16
• Founded2009
• Annual Revenue$4500000